Contract Pharma13h
Harbour BioMed & Insilico Partner on AI-Driven Antibody Discovery
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...
EurekAlert!1d
Harbour BioMed and Insilico Medicine achieve strategic collaboration to advance AI-driven antibody discovery and development
February 20, 2025, Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ...
News Medical2d
Anti-CD20 mAbs profiling
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
BioWorld6d
Biomissile’s multispecific antibodies harness NK cell engagers
Biomissile Pharmaceuticals Co. Ltd. is developing multispecific antibodies that overcome resistance associated with antibody-drug conjugates via its next-generation natural killer (NK) cell engagers.
TMCnet8d
Institute for Protein Innovation Receives Grant from Chan Zuckerberg Initiative to Develop Next-Generation Protein Tools for Neuroscience Research
The Institute for Protein Innovation (IPI), a nonprofit research institute dedicated to advancing protein science, today announced that it received a $500,000 grant from the Chan Zuckerberg Initiative ...
Next-generation mRNA vaccine delivery system uses biodegradable polymers
A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
Medical News Today21d
What to know about the thyroglobulin antibody (TgAb) test
A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...